Posted On: Tuesday, August 2nd, 2016
CPHA will be hosting a series of webinars throughout fall 2016 and winter 2017 to increase understanding of the stigma associated with sexually transmitted and blood-borne infections (STBBIs) as well as sexuality and substance use. CPHA is inviting the public health community to submit webinar proposals focused on understanding and reducing STBBI-related stigma. Click here… Read more »
Posted On: Tuesday, August 2nd, 2016
The “Hepatitis C Treatment Options: Basic Information for Patients” is now available directly on the Hepatitis Education Canada website. The tool allows people to input information about their own: • Genotype • treatment history, and • cirrhosis status to display selected CASL & AASLD recommended treatments. Also included on site are videos to help people… Read more »
Posted On: Monday, July 25th, 2016
On July 11, 2016, Health Canada licensed the sale and use of a new fixed-dose combination of two anti-hepatitis C virus (HCV) drugs sold under the brand name Epclusa and made by the pharmaceutical company Gilead Sciences. Epclusa contains the following medicines: sofosbuvir – 400 mg velpatasvir – 100 mg Clinical trials In clinical trials,… Read more »
Posted On: Monday, July 18th, 2016
2016 World Hepatitis Day Events in British Columbia Collected by Pacific AIDS Network FRASER Sponsoring Agency: Stride with Purpose Program at the Lower Mainland Purpose Society When: Thursday, July 28 from 8:00am – 9:00am Where: Lougheed Skytrain Station Event Details: Stride with Purpose will be at the Lougheed Skytrain Station handing out treats and… Read more »
Posted On: Monday, July 4th, 2016
AHC Atlantic Members Meeting – June 6-7, 2016 For those of you who weren’t there, we had a great 1.5 days of meetings in Halifax! It was a really great opportunity to connect with new members, and long-standing members that we had never met yet in person. We are awaiting the final report which we… Read more »
Posted On: Monday, June 20th, 2016
OTTAWA, June 16, 2016 – The Honourable Jane Philpott, Canada’s minister for health, reaffirmed today Canada’s commitment to participate in the global fight against viral hepatitis. Speaking at a breakfast on Parliament Hill organized by the Canadian Society for International Health (CSIH), Philpott said to the health professionals, government officials, civil society representatives and hepatitis… Read more »
Posted On: Sunday, May 29th, 2016
The Hepatitis C Treatment Information Project (Hep C TIP) has changed its website address. If your website or information collection includes information about our Hep C TIP, please update your links. If your website or information collection doesn’t currently include information about our Hepatitis C Treatment Information Project (Hep C TIP), please add it to… Read more »
Posted On: Tuesday, May 17th, 2016
Join the Public Health Agency of Canada as the Canadian Society for International Health (CSIH) presents on activities to commemorate World Hepatitis Day Canada 2016 upcoming on July 28. CSIH is the secretariat for the Global Hepatitis C Network and works to increase awareness and understanding of hepatitis in Canada and abroad. Last year, the… Read more »
Posted On: Monday, May 2nd, 2016
Holkira Pak is now indicated for people with HIV/Hep C co-infection or post liver transplant The Holkira Pak product monograph has been updated to include that people who are co-infected with HIV and Hep C or who have had a liver transplant can be treated with this drug combination. Holkira Pak is a combination of… Read more »
Posted On: Monday, April 25th, 2016
Posted On: Monday, April 4th, 2016
Surplus in the Trust Fund for the 1986-1990 Hepatitis C Settlement Agreement In direct contradiction to the promise made by the Liberal Party of Canada during the 2015 election campaign not to attempt to recover the quarter-billion dollar surplus in the Trust Fund for the 1986-1990 Hepatitis C Settlement Agreement, the Attorney General of Canada… Read more »
Posted On: Sunday, March 20th, 2016
Last week the AHC released a position paper on the need for a national strategy to eliminate hepatitis C. We will be hosting a briefing and Q&A on this position paper on: Tuesday, March 22 at 12:30 ET. Call-in #: 1-866-465-6318 or 416-915-1249 Conference Code: 2760674 Watch for similar briefing/Q&A sessions for each of… Read more »
